Top Markets
Coin of the day
Lin BioScience, Inc. Lin BioScience, Inc.

Lin BioScience, Inc.

6696
Rank in Stocks #5730
Lin BioScience, Inc. is an innovative biopharmaceutical company focused on... Lin BioScience, Inc. is an innovative biopharmaceutical company focused on developing novel therapies across oncology, ophthalmology, and metabolic diseases. Its robust pipeline includes LBS-008, an orally administered treatment currently in Phase 3 clinical trials for adolescent Stargardt disease (STGD1) and Phase 2/3 trials for dry age-related macular degeneration (Dry AMD), both aimed at evaluating its safety and effectiveness. Other key candidates are LBS-007, a natural non-ATP CDC7 inhibitor designed to combat various cancers; LBS-002, an anti-tubulin compound targeting primary and metastatic brain tumors; and LBS-009, an oral medication for non-alcoholic fatty liver disease and Type 2 diabetes. The company is headquartered in Taipei, Taiwan.
Share Price
$29.86
Last synced: 2026-08-19
Market Cap
$2.48B
Change (1 day)
4.92%
Change (1 year)
502.82%
Country
TW
Trade Lin BioScience, Inc. (6696)

Category

Stock price history for Lin BioScience, Inc. (6696)
Highest end of day price: $26.88 on 2026-08-01

Lowest end of day price: $1.30 on 2018-10-01
Stock price history of Lin BioScience, Inc. from 2018 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -3.77%
2025 202.95%
2024 13.59%
2023 -31.65%
2022 -22.82%
2021 101.12%
2020 278.57%
2019 -21.27%
2018 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$543.89 39.79%
US
$1.05K 48.43%
NL
$122.63 -12.65%
AU
$142.84 469.08%
US
$761.35 6.65%
CH